GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » PS Ratio

Aetna (AET) PS Ratio : 1.15 (As of Apr. 26, 2024)


View and export this data going back to 1968. Start your Free Trial

What is Aetna PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aetna's share price is $212.70. Aetna's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was $185.73. Hence, Aetna's PS Ratio for today is 1.15.

The historical rank and industry rank for Aetna's PS Ratio or its related term are showing as below:

AET's PS Ratio is not ranked *
in the Healthcare Plans industry.
Industry Median: 0.66
* Ranked among companies with meaningful PS Ratio only.

Aetna's Revenue per Sharefor the three months ended in Sep. 2018 was $46.89. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was $185.73.

Back to Basics: PS Ratio


Aetna PS Ratio Historical Data

The historical data trend for Aetna's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna PS Ratio Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.55 0.63 0.70 1.00

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 1.00 0.92 1.00 1.09

Competitive Comparison of Aetna's PS Ratio

For the Healthcare Plans subindustry, Aetna's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aetna's PS Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Aetna's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aetna's PS Ratio falls into.



Aetna PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Aetna's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=212.70/185.734
=1.15

Aetna's Share Price of today is $212.70.
Aetna's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $185.73.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Aetna  (NYSE:AET) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Aetna PS Ratio Related Terms

Thank you for viewing the detailed overview of Aetna's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

Paul Tudor Jones Continues to Buy Apple, Alibaba

By Tiziano Frateschi Tiziano Frateschi 11-29-2018

Analysts Take Action on Health Care Stocks

By Alberto Abaterusso Alberto Abaterusso 01-23-2018

3 Strong ROC Stocks to Buy. Part 2

By Tiziano Frateschi Tiziano Frateschi 01-14-2015

5 Health Care Stocks Gurus Are Buying

By Tiziano Frateschi Tiziano Frateschi 10-30-2018

Maintain a Healthy Portfolio with Aetna

By Victor Selva Victor Selva 03-24-2014

Leucadia National Buys Aetna, Monsanto

By Tiziano Frateschi Tiziano Frateschi 03-12-2018

5 Companies Reach 52-Week Highs

By yifan900 yifan900 11-29-2016

14 Best Undervalued Stocks of the Week

By Benjamin Clark Benjamin Clark 08-09-2016